Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa

Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1036-1046. doi: 10.1016/S2468-1253(21)00275-2. Epub 2021 Sep 9.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally and is estimated to affect approximately 25% of the world's population. Data about the prevalence and incidence of NAFLD in Africa are scarce, but the prevalence is estimated to be 13·5% for the general population. This is likely to be an underestimate considering the increasing burden of non-communicable diseases, particularly the rising prevalence of obesity and type 2 diabetes, driven by the overlapping challenges of food insecurity, nutritional transition, and associated increased consumption of calorie-dense foods. Establishing the true prevalence of NAFLD, raising public awareness around the risk factors behind the increase in NAFLD, and proactively addressing all components of metabolic syndrome will be important to combat this silent epidemic, which will have long-term health-care costs and economic consequences for the region.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Africa South of the Sahara / epidemiology
  • Awareness
  • Cost of Illness
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / epidemiology
  • Disease Management
  • Dyslipidemias / complications
  • Dyslipidemias / epidemiology
  • Female
  • Gastrointestinal Microbiome
  • Health Care Costs
  • Humans
  • Hypertension / complications
  • Hypertension / epidemiology
  • Incidence
  • Male
  • Metabolic Syndrome / complications
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Noncommunicable Diseases / economics*
  • Noncommunicable Diseases / epidemiology
  • Obesity / complications
  • Obesity / epidemiology
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / epidemiology
  • Prevalence
  • Prognosis
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / epidemiology
  • Risk Factors
  • Social Determinants of Health / trends*